𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy of polyadenylic.polyuridylic acid in the treatment of chronic active hepatitis B

✍ Scribed by Ki Baik Hahm; Kwang Hyub Han; Won Ho Kim; Dae Soon Yim; Chae Yoon Chon; Young Myung Moon; Jin Kyung Kang; In Suh Park; Jung Koo Youn; Evelyne Deschamps de Paillette

Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
626 KB
Volume
16
Category
Article
ISSN
0192-0561

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Measurement of polyadenylic acid by hybr
Measurement of polyadenylic acid by hybridization with polyuridylic acid: A source of error due to the lability of tritiated polyuridylic acid in trichloroacetic acid
✍ David L. Williams; Hanna Klett πŸ“‚ Article πŸ“… 1978 πŸ› Elsevier Science 🌐 English βš– 474 KB

During brief exposure to trichloroacetic acid at 0 degree C, significant amounts of tritiated polyuridylic acid are converted to acid-soluble products. The loss of polymeric radioactivity is dependent on both acid concentration and the time of exposure to acid. When trichloroacetic acid precipitatio

Efficacy of lamivudine in HBeAg-negative
Efficacy of lamivudine in HBeAg-negative chronic hepatitis B
✍ Mario Rizzetto πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 136 KB

## Abstract Hepatitis B e antigen (HBeAg)‐negative chronic hepatitis B results from infection with hepatitis B virus mutants unable to produce HBeAg. It accounts for 7–30% of patients with chronic hepatitis B virus (HBV) worldwide, with the highest rates reported for Mediterranean Europe and Asia.

Long-term efficacy and safety of adefovi
Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen–positive chronic hepatitis B
✍ Patrick Marcellin; Ting-Tsung Chang; Seng G. Lee Lim; William Sievert; Myron Ton πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 277 KB πŸ‘ 1 views

Treatment of 171 patients with hepatitis B e antigen (HBeAg)-positive chronic hepatitis B (CHB) with adefovir dipivoxil (ADV) 10 mg over 48 weeks resulted in significant histological, virological, serological, and biochemical improvement compared with placebo. The long-term efficacy and safety of AD